We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+11.61%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$393M
Cap. Flow
+$218M
Cap. Flow %
9.84%
Top 10 Hldgs %
19.94%
Holding
4,413
New
404
Increased
2,760
Reduced
745
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 12.54%
2 Financials 7.15%
3 Consumer Discretionary 5.77%
4 Industrials 3.78%
5 Healthcare 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTG icon
3776
Alta Equipment Group
ALTG
$247M
$796 ﹤0.01%
126
+120
+2,000% +$607
AOSL icon
3777
Alpha and Omega Semiconductor
AOSL
$975M
$796 ﹤0.01%
+31
New +$674
DSGN icon
3778
Design Therapeutics
DSGN
$851M
$792 ﹤0.01%
235
+204
+658% +$763
ATLO icon
3779
AMES National
ATLO
$277M
$784 ﹤0.01%
44
+30
+214% +$522
HAPN
3780
Happen Inc
HAPN
$2.37B
$782 ﹤0.01%
65
+30
+86% +$312
DNUT icon
3781
Krispy Kreme
DNUT
$538M
$774 ﹤0.01%
266
-56
-17% -$195
PBFS icon
3782
Pioneer Bancorp
PBFS
$433M
$770 ﹤0.01%
64
+47
+276% +$540
IH
3783
iHuman
IH
$65.9M
$763 ﹤0.01%
+305
New +$680
BVFL icon
3784
BV Financial
BVFL
$187M
$762 ﹤0.01%
+50
New +$752
AIV
3785
Aimco
AIV
$381M
$761 ﹤0.01%
88
-10
-10% -$81
RM icon
3786
Regional Management Corp
RM
$307M
$760 ﹤0.01%
26
+3
+13% +$87
PHAT icon
3787
Phathom Pharmaceuticals
PHAT
$684M
$758 ﹤0.01%
79
+42
+114% +$232
PRAX icon
3788
Praxis Precision Medicines
PRAX
$8.85B
$757 ﹤0.01%
18
+7
+64% +$267
DFH icon
3789
Dream Finders Homes
DFH
$1.37B
$754 ﹤0.01%
30
-45
-60% -$1.01K
EML icon
3790
Eastern Company
EML
$148M
$753 ﹤0.01%
33
+32
+3,200% +$720
NPWR icon
3791
NET Power
NPWR
$131M
$748 ﹤0.01%
303
-205
-40% -$430
COYA icon
3792
Coya Therapeutics
COYA
$107M
$742 ﹤0.01%
+129
New +$747
RXST icon
3793
RxSight
RXST
$255M
$741 ﹤0.01%
57
+33
+138% +$496
INFU icon
3794
InfuSystem Holdings
INFU
$253M
$730 ﹤0.01%
+117
New +$646
FTHY
3795
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$496M
$726 ﹤0.01%
49
+1
+2% +$14
OCUL icon
3796
Ocular Therapeutix
OCUL
$1.89B
$724 ﹤0.01%
78
+40
+105% +$313
BCAX
3797
Bicara Therapeutics
BCAX
$1.68B
$724 ﹤0.01%
78
-24
-24% -$286
GOTU icon
3798
Gaotu Techedu
GOTU
$444M
$722 ﹤0.01%
200
-313
-61% -$1.07K
AVXL icon
3799
Anavex Life Sciences
AVXL
$290M
$719 ﹤0.01%
78
+45
+136% +$384
NVCT icon
3800
Nuvectis Pharma
NVCT
$631M
$717 ﹤0.01%
+96
New +$871

Similar funds

EverSource Wealth Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, EverSource Wealth Advisors held 4,413 positions worth $2.21B, up 22% from $1.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EverSource Wealth Advisors deployed $218M of net new capital in Q2 2025, opening 404 new positions and adding to 2,760 existing holdings. Its largest new stake was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard International Dividend Appreciation ETF, an estimated $10.2M trimmed.

  • EverSource Wealth Advisors's largest Q2 2025 buy was Praxis Impact Large Cap Value ETF: 1,041,021 shares worth $29.5M.
  • EverSource Wealth Advisors added most to Vanguard 0-3 Month Treasury Bill ETF in Q2 2025, an estimated $9.75M increase.
  • EverSource Wealth Advisors's biggest Q2 2025 reduction was Vanguard International Dividend Appreciation ETF, cutting an estimated $10.2M.
  • EverSource Wealth Advisors fully exited State Street SPDR S&P Regional Banking ETF in Q2 2025, selling an estimated $2.75M.
  • EverSource Wealth Advisors's ten largest holdings make up 20% of its $2.21B portfolio in Q2 2025.
  • EverSource Wealth Advisors opened 404 new positions and closed 164 in Q2 2025.
  • EverSource Wealth Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.

Based on EverSource Wealth Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.